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journal homepage: www.j -bgm.comABSTRACTCrosstalk between p38MAPK and ERK in
ceffecine-treated human leukemia U937 cellsYing-Jung Chen, Wen-Hsin Liu, Long-Sen ChangInstitute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, TaiwanBackgrounds: Mitogen-activated protein kinases (MAPKs) include extracellular signal-activated protein kinase (ERK), c-Jun
NH2-terminal kinase (JNK) and p38 MAPK. The MAPKs have been implicated in the control of signal transduction pathways to
regulate critical cellular functions including cell growth, differentiation and apoptosis. Nevertheless, the mechanism un-
derlying the regulation of balance in these opposing signaling events and the potential interactions between these MAPK
pathways remain poorly realized. Much evidence suggests that phosphatases including MAKP phosphatase-1 (MKP-1) and
protein phosphatase 2A (PP2A) mediate cross-talk between p38 MAPK/JNK pathway and ERK pathway in cells. Previous
studies suggested that caffeine led to a crosstalk between p38 MAPK and ERK in human leukemia U937 cells. Thus, the
functional involvement of PP2A and MEK-1 in this crosstalk was further explored in caffeine-treated U937 cells.
Materials and Methods: After treatment of human leukemia U937 cells with 50 mM caffeine for suitable time intervals, the
expression levels of MKP-1, PP2Aca (protein phosphatase 2A catalytic subunit a), phospho-ERK and phospho-p38 MAPK were
detected using RT-PCR, or western blotting analyses. Moreover, regulation of MEK-1 and PP2Aca expression in caffeine-
treated cells was analyzed by promoter luciferase assay and chromatin immunoprecipitation assay.
Results: Caffeine induced p38 MAPK activation and ERK inactivation, and caffeine treatment elicited MKP-1 down-
regulation and PP2Aca up-regulation. The transfection of constitutively active MEK1 or pretreatment with SB202190 (p38
MAPK inhibitor) abolished the caffeine effect on MKP-1 and PP2Aca expression. Caffeine repressed ERK-mediated c-Fos
phosphorylation but evoked p38 MAPK-mediated CREB phosphorylation. Knockdown of c-Fos and CREB by siRNA showed that
c-Fos and CREB were responsible for MKP-1 and PP2Aca expression, respectively. Promoter and chromatin immunopreci-
pitating assay supported the role of c-Fos and CREB in regulating MKP-1 and PP2Aca expression. Moreover, transfection of
dominant negative MKP-1 cDNA led to p38 MAPK activation and PP2Aca downregulation in U937 cells, while PP2A inhibitor
attenuated caffeine-induced ERK inactivation and MKP-1 down-regulation.
Conclusion: Our data reveal that ERK-mediated MKP-1 expression inactivation promotes p38 MAPK activation and PP2Aca
expression in caffeine-treated cells, while suppression of p38 MAPK-mediated PP2Aca expression leads to ERK activation and
MKP-1 expression. The negative feedback loop based on the expression and activity of MKP-1 and PP2Aca critically regulates
ERK and p38 MAPK phosphorylation in untreated and caffeine-treated U937 cells. Noticeably, a number of in vivo and in vitro
studies have shown that caffeine modulates innate and adaptive immune response. Several lines of evidence indicate that
MKP-1 is a critical regulator of the innate immune response. The results from this study suggest the molecular mechanism of
caffeine in regulating MKP-1 expression, and thus the relationship between the caffeine immuno-modulatory effect and
MKP-1 expression merits further study.2214-0247/$36 Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
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